We present a case of hypersensitivity pneumonitis caused by intranasal abuse of the prescription narcotic hydrocodone. The patient's clinical course was complicated by acute respiratory failure. A chest radiograph showed diffuse bilateral opacities. The patient was treated with noninvasive ventilation, a high dose of intravenous steroids, and bronchodilators, resulting in improvement of symptoms and radiographic appearance.
A common controlled prescription drug for pain is oral hydrocodone. According to a report from the National Center on Addiction and Substance Abuse at Columbia University, 99% of all hydrocodone in the world is used in the USA ( 1 ). Snorting is a new route of hydrocodone abuse, which results in a rapid onset of eff ects, causing almost immediate pain relief and euphoria. But when the drug is snorted, there is a much greater risk of toxic eff ects, including hypersensitivity pneumonitis causing respiratory failure. Such was the case in the patient described herein.
CASE DESCRIPTION
A 52-year-old Native American woman came in with symptoms of dyspnea, wheezing, hypoxia, dry cough, and subjective fever. She was a chronic smoker. She previously had coronary artery bypass graft and stenting at an outside facility. She reported snorting hydrocodone daily for the last 2 months.
On examination she was afebrile, tachypneic, and hypoxic on room air, with an oxygen saturation of 84%. Chest exam revealed wheezes. She had mild leukocytosis and a normal metabolic panel, cardiac panel, D-dimer, and brain natriuretic peptide (Table 1) . A chest radiograph showed diff use patchy areas of ground-glass airspace disease bilaterally (Figure 1 ) .
High-resolution lung computed tomography showed mosaic attenuation of lungs with scattered areas of ground-glass opacity interspersed with more lucent areas of lung along with mild paraseptal emphysema (Figure 2 ) . An echocardiogram showed normal left ventricular function with no regional wall motion abnormality.
Th e patient was treated with high-fl ow oxygen, bronchodilators, and high-dose intravenous steroids. She was also started empirically on antibiotics. Th e following day she remained dyspneic and hypoxic with an increased oxygen requirement Leukocyte count (×10 9 /L) 11.5
Blood urea nitrogen (mg/dL) 8
Creatinine (mg/dL) 0.8
Brain natriuretic peptide (pg/mL) 50
Troponin (ng/mL) <0.012 discharged from the hospital with near complete resolution of her symptoms. She was switched to oral prednisone, which was tapered during the next 2 weeks. A follow-up chest radiograph showed complete resolution of the infi ltrate.
DISCUSSION
Hypersensitivity pneumonitis, also called extrinsic allergic alveolitis, is an immunologic reaction to a wide variety of inhaled organic and inorganic antigens. Th ese include but are not limited to microorganisms (bacteria, fungi, mycobacteria, and virus), agricultural aerosols, animal protein, and many chemical reagents. Recurrent exposure leads to chronic infl ammation and fi brotic lung disease. Th erefore, early diagnosis and avoidance of the exposed allergen is the key to treatment.
Patients are exposed to these allergens as a result of their occupation or lifestyle. Dyspnea, dry cough, fever, weight loss, and easy fatigability are the most common presenting symptoms ( 2 ) . Acute symptoms are seen within 4 to 12 hours of antigen exposure and are alleviated by removal of the off ending agent. Repeat exposure after abstinence often causes recurrence of the symptoms. Th e disease presentation, severity, and latency are infl uenced by the concentration of the inhaled antigen, duration of exposure, frequency of exposure, and interval between exposures.
Several diff erent criteria for diagnosis of hypersensitivity pneumonitis have been described, but they were developed before the advent of high-resolution computed tomography and bronchoalveolar lavage. Th ey are usually for acute cases and depend on an abnormal chest radiograph or positive serum precipitins, which are often absent (3) (4) (5) . Most of the diagnostic criteria include one or all of the following: ( 1 ) known exposure to the antigen; ( 2 ) compatible clinical, radiographic, and physiologic fi ndings; ( 3 ) positive inhalation challenge test; ( 4 ) histopathology changes of noncaseating granuloma or mononuclear infi ltrate or bronchoalveolar lavage with lymphocytosis. Imaging studies including chest radiograph and high-resolution computed tomography show reticular, nodular, and/or groundglass opacities. Chronic cases due to repeated exposure show fi brotic changes with volume loss ( 6 ) .
In our patient, the antigen was inorganic powdered hydrocodone, which after snorting triggered a severe allergic response leading to hypersensitivity pneumonitis and acute respiratory failure. Continued recreational abuse by patients over time could lead to parenchymal lung fi brosis. Drug counseling and rehabilitation should be part of overall management.
